Cylene Pharmaceuticals Secures $15,635,924 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=03166fbe-6d44-4c5e-9ad0-00c890f0d385&Preview=1 - Date
8/11/2011 - Company Name
Cylene Pharmaceuticals - Mailing Address
5820 Nancy Ridge Drive San Diego, CA 92121 - Company Description
Cylene Pharmaceuticals, Inc. is a privately held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. - Website
http://www.cylenepharma.com - Transaction Type
Debt - Transaction Amount
$15,635,924 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
